APA
PRCT icon

American Portfolios Advisors’s Procept Biorobotics PRCT Stock Holding History

American Portfolios Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.49K Hold
60
– – ﹤0.01% 3059
2022
Q2 		$1.96K Sell
60
-143
-70% -$5.2K ﹤0.01% 3139
2022
Q1 		$7.1K Sell
203
-122
-38% -$2.94K ﹤0.01% 2827
2021
Q4 		$8.13K Buy
325
+305
+1,525% +$11.3K ﹤0.01% 2706
2021
Q3 		$763 Buy
+20
New +$768 ﹤0.01% 3344

Other funds holding PRCT

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

American Portfolios Advisors's PRCT Position: Q3 2022 in Review

American Portfolios Advisors held its Procept Biorobotics (PRCT) position steady in Q3 2022 at 60 shares worth $2.49K. The position accounts for ﹤0.01% of the portfolio, ranked #3059.

American Portfolios Advisors first reported a position in PRCT in Q3 2021 and has held it in 5 quarters since. The position peaked at $8.13K in Q4 2021. 103 funds tracked by Wall St. Rank hold PRCT as of Q3 2022.

  • American Portfolios Advisors held 60 shares of Procept Biorobotics worth $2.49K as of Q3 2022.
  • American Portfolios Advisors left its Procept Biorobotics share count unchanged in Q3 2022.
  • Procept Biorobotics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3059 holding.
  • American Portfolios Advisors first reported a position in Procept Biorobotics in Q3 2021 and has held it in 5 quarters since.
  • American Portfolios Advisors's Procept Biorobotics position peaked at $8.13K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.